Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-083215
Filing Date
2025-06-06
Accepted
2025-06-06 16:53:23
Documents
1
Period of Report
2025-06-05

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 5448
  Complete submission text file 0000950170-25-083215.txt   6959
Mailing Address 47 HULFISH STREET PRINCETON NJ 08542
Business Address 47 HULFISH STREET PRINCETON NJ 08542 (609) 662-2000
AMICUS THERAPEUTICS, INC. (Issuer) CIK: 0001178879 (see all company filings)

EIN.: 200422823 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O NEUROCRINE BIOSCIENCES, INC. 12780 EL CAMINO REAL SAN DIEO CA 92130
Business Address
ROBERTS EIRY (Reporting) CIK: 0001727606 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33497 | Film No.: 251031815